Live from the NIH registry
Studies recruiting near Tucson right now
Top 25 of 470 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: SWOG Cancer Research Network
Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH
Pulmonary Arterial Hypertension
Phase 3
Interventional 20 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Lupus Landmark Study: A Prospective Registry and Biorepository
Systemic Lupus Erythematosus (SLE), Lupus Nephritis
N/A
Observational 3,500 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Lupus Research Alliance
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Center for Neurosciences — Tucson, Arizona (5.4 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Tucson, Arizona (5.4 mi)
· Sponsor: Sameek Roychowdhury
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Tucson, Arizona (5.4 mi)
· Sponsor: GlaxoSmithKline
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Heart Failure
Phase 2
Interventional 200 participants sought
TMC Hlthcr Clin Res Office — Tucson, Arizona (5.4 mi)
· Sponsor: Novo Nordisk A/S
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
The University of Arizona Cancer Center - North Campus — Tucson, Arizona (5.4 mi)
· Sponsor: Eli Lilly and Company
Wellness Intervention for Smoking and HIV
HIV, Sleep
N/A
Interventional 200 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Transcranial Magnetic Stimulation of the Default Mode Network to Improve Sleep
Insomnia, Primary
N/A
Interventional 20 participants sought
University of Arizona Psychiatry Department — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Advanced Cancer
Phase 1
Interventional 164 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: Riboscience, LLC.
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 2,000 participants sought
Banner University Medical Center - Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Breast Neoplasms, Triple Negative Breast Neoplasms
Phase 3
Interventional 2,400 participants sought
University of Arizona Cancer Center ( Site 0035) — Tucson, Arizona (5.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Media and Mental Health
Mental and Behavioral Disorders, Mental Resilience
N/A
Interventional 70 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Alabama at Birmingham
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Locally Advanced Cervical Cancer
Phase 3
Interventional 800 participants sought
Research Site — Tucson, Arizona (5.4 mi)
· Sponsor: AstraZeneca
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Tricuspid Regurgitation
N/A
Interventional 65 participants sought
Tucson Medical Center — Tucson, Arizona (5.4 mi)
· Sponsor: Laplace Interventional, Inc
A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators
Cystic Fibrosis
N/A
Observational 400 participants sought
Tucson Cystic Fibrosis Center — Tucson, Arizona (5.4 mi)
· Sponsor: Nicole Hamblett
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
Solid Tumor
Phase 1, Phase 2
Interventional 156 participants sought
SCRI - Arizona Oncology Associates — Tucson, Arizona (5.4 mi)
· Sponsor: Corbus Pharmaceuticals Inc.
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
SLE, SLE (Systemic Lupus)
Phase 1
Interventional 24 participants sought
AARA Clinical Research — Tucson, Arizona (5.4 mi)
· Sponsor: Cullinan Therapeutics Inc.
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Chronic Obstructive Pulmonary Disease
Phase 3
Interventional 942 participants sought
Tucson Clinical Research Institute- Site Number : 8400006 — Tucson, Arizona (5.4 mi)
· Sponsor: Sanofi
A Randomized Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy in Patients With Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease
Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction
N/A
Interventional 750 participants sought
Banner - University Medical Center Tucson — Tucson, Arizona (5.4 mi)
· Sponsor: Pulnovo Medical, Inc.
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive
N/A
Interventional 739 participants sought
University of Arizona Cancer Center-Orange Grove Campus — Tucson, Arizona (5.4 mi)
· Sponsor: SWOG Cancer Research Network
Enhancing Language Function in Aphasia
Aphasia, Acquired, Language Disorders
N/A
Interventional 30 participants sought
University of Arizona — Tucson, Arizona (5.4 mi)
· Sponsor: University of Arizona
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Metastatic Breast Cancer
Phase 3
Interventional 600 participants sought
University of Arizona - Cancer Center — Tucson, Arizona (5.4 mi)
· Sponsor: LeonaBio